Recon: J&J and Sanofi halt E.coli vaccine study over weak efficacy data; Pfizer nabs new FDA indication for Adcetris
ReconJason Scott
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)